ClinicalTrials.gov
public full text
Public Domain
Sublingual Misoprostol in Decreasing Blood Loss Prior to Myomectomy
The aim of the study is to compare the effectiveness of sublingual administered prostaglandin E1 synthetic analogue (misoprostol) 400 microgram versus placebo before myomectomy to decrease blood loss during and after the operation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy#1094435
- Impact of Misoprostol on Blood Loss In Myomectomy Operations#979867
- Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors#856614
- Dienogest for Treatment of Adenomyotic Uteri#1010378
- Management and Outcomes of Perioperative Care Among European Diabetic Patients#907546
Record · ID 1152705
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive